IMIDomics Competitors and Similar CompaniesClear all

IMIDomics's competitors and similar companies include Genfit, Alpha Diagnostic, Roche and BioArctic.
IMIDomics
IMIDomics
IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients.
Genfit
Genfit
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
Alpha Diagnostic
Alpha Diagnostic
Alpha Diagnostic International (ADI) is a biotech company providing diagnostic reagents and test kits for animal and human diseases.
Roche
Roche
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
BioArctic
BioArctic
BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases.
Founding Date
Founding Date
2015
Founding Date
1999
Founding Date
1993
Founding Date
1896
Founding Date
2003
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
HQ
Locations
Loos, FR HQ
Cambridge, US
Locations
San Antonio, US HQ
San Antonio, US
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
North Ryde, AU
Sydney, AU
Wien, AT
Dhaka, BD
see more
Locations
Stockholm , SE HQ
Employees
Employees
3
Employees
180
Employees
N/A
Employees
103,249
Employees
107
Valuation ($)
Valuation ($)
N/A
Valuation ($)
280.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.3 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€65.4m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
CHF61.5b (FY, 2025)
Revenue (est.)
kr2b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
€302k (FY, 2025)
Cost of goods
N/A
Cost of goods
CHF13.1b (FY, 2025)
Cost of goods
kr59.2m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
€70.8m (FY, 2025)
Gross profit
N/A
Gross profit
CHF50.5b (FY, 2025)
Gross profit
kr1.9b (FY, 2025)
Net income
Net income
N/A
Net income
(€86m) (FY, 2025)
Net income
N/A
Net income
CHF13.8b (FY, 2025)
Net income
kr1b (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 16.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 7.8b
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Genfit
HQ
Loos, FR
Employees
180

GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.

View company
Alpha Diagnostic
HQ
San Antonio, US

Alpha Diagnostic International (ADI) is a biotech company providing diagnostic reagents and test kits for animal and human diseases.

View company
Roche
HQ
Basel, CH
Employees
103,249

Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.

View company
BioArctic
HQ
Stockholm , SE
Employees
107

BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases.

View company